Nano-X Imaging (NNOX) Stock Forecast, Price Target & Predictions
NNOX Stock Forecast
Nano-X Imaging stock forecast is as follows: an average price target of $18.00 (represents a 217.46% upside from NNOX’s last price of $5.67) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
NNOX Price Target
The average price target for Nano-X Imaging (NNOX) is $18.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $18.00 to $18.00. This represents a potential 217.46% upside from NNOX's last price of $5.67.
NNOX Analyst Ratings
According to 2 Wall Street analysts, Nano-X Imaging's rating consensus is 'Buy'. The analyst rating breakdown for NNOX stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Nano-X Imaging Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Apr 02, 2024 | Ross Osborn | Cantor Fitzgerald | $18.00 | $10.33 | 74.25% | 217.46% |
The latest Nano-X Imaging stock forecast, released on Apr 02, 2024 by Ross Osborn from Cantor Fitzgerald, set a price target of $18.00, which represents a 74.25% increase from the stock price at the time of the forecast ($10.33), and a 217.46% increase from NNOX last price ($5.67).
Nano-X Imaging Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $18.00 |
| Last Closing Price | $5.67 | $5.67 | $5.67 |
| Upside/Downside | -100.00% | -100.00% | 217.46% |
In the current month, the average price target of Nano-X Imaging stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Nano-X Imaging's last price of $5.67. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Apr 02, 2024 | Cantor Fitzgerald | Overweight | Overweight | Hold |
| Jan 19, 2024 | Cantor Fitzgerald | Overweight | Overweight | Hold |
| Sep 08, 2023 | Alliance Global Partners | - | Buy | Initialise |
Nano-X Imaging's last stock rating was published by Cantor Fitzgerald on Apr 02, 2024. The company gave NNOX a "Overweight" rating, the same as its previous rate.
Nano-X Imaging Financial Forecast
Nano-X Imaging Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.45M | $2.13M | $2.44M | $2.20M | $1.81M | $1.30M |
| Avg Forecast | $41.48M | $28.34M | $20.20M | $14.16M | $9.35M | $8.08M | $7.22M | $5.85M | $4.69M | $3.91M | $3.93M | $4.42M | $2.82M | $2.90M | $3.15M | $2.90M | $2.65M | $2.81M | $2.35M | $2.38M | $750.00K |
| High Forecast | $41.48M | $28.34M | $20.20M | $14.16M | $9.35M | $8.08M | $7.22M | $5.85M | $4.69M | $5.00M | $3.93M | $4.42M | $3.57M | $2.90M | $3.15M | $2.90M | $2.65M | $2.81M | $2.35M | $2.38M | $750.00K |
| Low Forecast | $41.48M | $28.34M | $20.20M | $14.16M | $9.35M | $8.08M | $7.22M | $5.85M | $4.69M | $3.08M | $3.93M | $4.42M | $2.10M | $2.90M | $3.15M | $2.90M | $2.65M | $2.81M | $2.35M | $2.38M | $750.00K |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.85% | 0.81% | 0.87% | 0.94% | 0.76% | 1.74% |
Nano-X Imaging's average Quarter revenue forecast for Jun 23 based on 1 analysts is $3.15M, with a low forecast of $3.15M, and a high forecast of $3.15M. NNOX's average Quarter revenue forecast represents a 28.93% increase compared to the company's last Quarter revenue of $2.45M (Mar 23).
Nano-X Imaging EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-18.31M | $12.10M | $-15.05M | $-15.92M | $-19.08M | $-22.04M |
| Avg Forecast | $-8.30M | $-5.67M | $-4.04M | $-2.83M | $-1.87M | $-1.62M | $-1.44M | $-1.17M | $-938.38K | $-781.62K | $-786.13K | $-883.00K | $-564.67K | $-580.00K | $-631.00K | $-579.00K | $-529.00K | $-563.00K | $-469.00K | $-477.00K | $-150.00K |
| High Forecast | $-8.30M | $-5.67M | $-4.04M | $-2.83M | $-1.87M | $-1.62M | $-1.44M | $-1.17M | $-938.38K | $-615.55K | $-786.09K | $-883.00K | $-420.50K | $-580.00K | $-631.00K | $-579.00K | $-529.00K | $-563.00K | $-469.00K | $-477.00K | $-150.00K |
| Low Forecast | $-8.30M | $-5.67M | $-4.04M | $-2.83M | $-1.87M | $-1.62M | $-1.44M | $-1.17M | $-938.38K | $-1.00M | $-786.16K | $-883.00K | $-714.84K | $-580.00K | $-631.00K | $-579.00K | $-529.00K | $-563.00K | $-469.00K | $-477.00K | $-150.00K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31.63% | -22.88% | 26.73% | 33.94% | 40.01% | 146.90% |
1 analysts predict NNOX's average Quarter EBITDA for Mar 23 to be $-579.00K, with a high of $-579.00K and a low of $-579.00K. This is -104.78% lower than Nano-X Imaging's previous annual EBITDA (Dec 22) of $12.10M.
Nano-X Imaging Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-11.76M | $-44.84M | $-19.13M | $-19.61M | $-21.67M | $-20.18M |
| Avg Forecast | $3.76M | $-916.48K | $-3.89M | $-6.28M | $-8.24M | $-8.82M | $-9.29M | $-9.92M | $-12.45M | $-12.59M | $-12.53M | $-15.08M | $-17.59M | $-17.40M | $-15.37M | $-19.72M | $-24.94M | $-24.36M | $-14.69M | $-14.79M | $-19.14M |
| High Forecast | $3.76M | $-916.48K | $-3.89M | $-6.28M | $-8.24M | $-8.82M | $-9.29M | $-9.92M | $-12.45M | $-12.02M | $-12.53M | $-15.08M | $-14.08M | $-17.40M | $-15.37M | $-19.72M | $-24.94M | $-24.36M | $-14.69M | $-14.79M | $-19.14M |
| Low Forecast | $3.76M | $-916.48K | $-3.89M | $-6.28M | $-8.24M | $-8.82M | $-9.29M | $-9.92M | $-12.45M | $-12.59M | $-12.53M | $-15.08M | $-22.29M | $-17.40M | $-15.37M | $-19.72M | $-24.94M | $-24.36M | $-14.69M | $-14.79M | $-19.14M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.60% | 1.80% | 0.79% | 1.33% | 1.46% | 1.05% |
Nano-X Imaging's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. NNOX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Nano-X Imaging SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $8.96M | $9.68M | $11.33M | $12.23M | $12.39M | $12.86M |
| Avg Forecast | $349.75M | $238.95M | $170.34M | $119.42M | $78.83M | $68.16M | $60.89M | $49.32M | $39.56M | $32.95M | $33.14M | $37.23M | $23.81M | $24.45M | $26.60M | $24.41M | $22.30M | $23.74M | $19.77M | $20.11M | $6.32M |
| High Forecast | $349.75M | $238.95M | $170.34M | $119.42M | $78.83M | $68.16M | $60.89M | $49.32M | $39.56M | $42.20M | $33.15M | $37.23M | $30.14M | $24.45M | $26.60M | $24.41M | $22.30M | $23.74M | $19.77M | $20.11M | $6.32M |
| Low Forecast | $349.75M | $238.95M | $170.34M | $119.42M | $78.83M | $68.16M | $60.89M | $49.32M | $39.56M | $25.95M | $33.14M | $37.23M | $17.73M | $24.45M | $26.60M | $24.41M | $22.30M | $23.74M | $19.77M | $20.11M | $6.32M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.37% | 0.43% | 0.48% | 0.62% | 0.62% | 2.03% |
Nano-X Imaging's average Quarter SG&A projection for Jun 23 is $26.60M, based on 1 Wall Street analysts, with a range of $26.60M to $26.60M. The forecast indicates a 196.89% rise compared to NNOX last annual SG&A of $8.96M (Mar 23).
Nano-X Imaging EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.21 | $-0.86 | $-0.37 | $-0.38 | $-0.42 | $-0.42 |
| Avg Forecast | $0.06 | $-0.02 | $-0.07 | $-0.11 | $-0.14 | $-0.15 | $-0.16 | $-0.17 | $-0.21 | $-0.22 | $-0.22 | $-0.26 | $-0.30 | $-0.30 | $-0.27 | $-0.34 | $-0.43 | $-0.42 | $-0.25 | $-0.26 | $-0.33 |
| High Forecast | $0.06 | $-0.02 | $-0.07 | $-0.11 | $-0.14 | $-0.15 | $-0.16 | $-0.17 | $-0.21 | $-0.21 | $-0.22 | $-0.26 | $-0.24 | $-0.30 | $-0.27 | $-0.34 | $-0.43 | $-0.42 | $-0.25 | $-0.26 | $-0.33 |
| Low Forecast | $0.06 | $-0.02 | $-0.07 | $-0.11 | $-0.14 | $-0.15 | $-0.16 | $-0.17 | $-0.21 | $-0.22 | $-0.22 | $-0.26 | $-0.38 | $-0.30 | $-0.27 | $-0.34 | $-0.43 | $-0.42 | $-0.25 | $-0.26 | $-0.33 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.62% | 2.00% | 0.88% | 1.50% | 1.65% | 1.27% |
According to undefined Wall Street analysts, Nano-X Imaging's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to NNOX previous annual EPS of $NaN (undefined).
Nano-X Imaging Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| NVCR | NovoCure | $16.59 | $68.92 | 315.43% | Hold |
| NNOX | Nano-X Imaging | $5.67 | $18.00 | 217.46% | Buy |
| ALGN | Align | $210.78 | $421.00 | 99.73% | Buy |
| IART | Integra LifeSciences | $24.12 | $43.00 | 78.28% | Sell |
| HYPR | Hyperfine | $0.97 | $1.60 | 64.95% | Buy |
| EW | Edwards Lifesciences | $66.47 | $88.04 | 32.45% | Buy |
| MDT | Medtronic | $89.31 | $107.91 | 20.83% | Hold |
| PACB | Pacific Biosciences of California | $2.51 | $3.00 | 19.52% | Buy |
| DXCM | DexCom | $69.70 | $81.36 | 16.73% | Buy |
| ABT | Abbott Laboratories | $117.65 | $126.45 | 7.48% | Buy |
| AXNX | Axonics | $70.38 | $71.00 | 0.88% | Buy |
| SYK | Stryker | $366.90 | $317.96 | -13.34% | Buy |
| SWAV | ShockWave Medical | $334.75 | $258.17 | -22.88% | Hold |
NNOX Forecast FAQ
Is Nano-X Imaging a good buy?
Yes, according to 2 Wall Street analysts, Nano-X Imaging (NNOX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of NNOX's total ratings.
What is NNOX's price target?
Nano-X Imaging (NNOX) average price target is $18 with a range of $18 to $18, implying a 217.46% from its last price of $5.67. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Nano-X Imaging stock go up soon?
According to Wall Street analysts' prediction for NNOX stock, the company can go up by 217.46% (from the last price of $5.67 to the average price target of $18), up by 217.46% based on the highest stock price target, and up by 217.46% based on the lowest stock price target.
Can Nano-X Imaging stock reach $9?
NNOX's average twelve months analyst stock price target of $18 supports the claim that Nano-X Imaging can reach $9 in the near future.
What are Nano-X Imaging's analysts' financial forecasts?
Nano-X Imaging's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $30.5M (high $30.5M, low $30.5M), average EBITDA is $-6.1M (high $-6.1M, low $-6.1M), average net income is $-36.271M (high $-36.271M, low $-36.271M), average SG&A $257.2M (high $257.2M, low $257.2M), and average EPS is $-0.625 (high $-0.625, low $-0.625). NNOX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $104.18M (high $104.18M, low $104.18M), average EBITDA is $-20.835M (high $-20.835M, low $-20.835M), average net income is $-7.32M (high $-7.32M, low $-7.32M), average SG&A $878.46M (high $878.46M, low $878.46M), and average EPS is $-0.126 (high $-0.126, low $-0.126).
Did the NNOX's actual financial results beat the analysts' financial forecasts?
Based on Nano-X Imaging's last annual report (Dec 2022), the company's revenue was $8.58M, which missed the average analysts forecast of $10.19M by -15.82%. Apple's EBITDA was $-37.194M, beating the average prediction of $-2.038M by 1725.03%. The company's net income was $-105M, beating the average estimation of $-78.79M by 33.57%. Apple's SG&A was $45.63M, missing the average forecast of $85.93M by -46.90%. Lastly, the company's EPS was $-2.01, beating the average prediction of $-1.358 by 47.98%. In terms of the last quarterly report (Mar 2023), Nano-X Imaging's revenue was $2.45M, missing the average analysts' forecast of $2.9M by -15.47%. The company's EBITDA was $-18.312M, beating the average prediction of $-579K by 3062.70%. Nano-X Imaging's net income was $-11.761M, missing the average estimation of $-19.722M by -40.37%. The company's SG&A was $8.96M, missing the average forecast of $24.41M by -63.29%. Lastly, the company's EPS was $-0.21, missing the average prediction of $-0.34 by -38.24%